Skip to main content
. 2017 Aug 16;8(44):77963–77974. doi: 10.18632/oncotarget.20276

Table 1. The baseline characteristics of patients.

Characteristics No. of patients (%) Death % P-value MST* Log-rank P-value
Age
 < 60 248 (54.6) 213 85.9 0.991 25.72 0.293
 ≥ 60 206 (45.4) 177 85.9 23.65
Tabaccon exposure
 No 252 (55.5) 212 84.1% 0.224 25.31 0.064
 Yes 202 (44.5) 178 88.1% 22.85
Histological type
 AD 237 (52.2) 196 82.7 0.101 22.20 < 0.001
 SQU 164 (36.1) 148 90.2 23.54
 Others 53 (11.7) 46 86.8 36.59
Clinical stage
 I 95 (20.9) 65 68.4 < 0.001 43.82 < 0.001
 II 56 (12.2) 48 85.7 23.65
 III 263 (57.9) 240 91.3 17.38
 IV 40 (8.8) 37 92.5 19.96
Chemotherapy
 No 22 (4.8) 20 90.9 0.754# 14.82 0.006
 Yes 432 (95.2) 370 85.6 25.09
Surgery
 No 123 (27.1) 112 91.1 0.054 20.59 0.006
 Yes 331 (72.9) 278 84.0 25.42

*MST:median survival time, AD:adenocarcinoma, SQU: squamous carcinoma.

#Fisher exact P value.